World Brain Day 2015 Focuses on Epilepsy

By Mohammad Wasay, MD, FRCP, FAAN

A World Federation of Neurology (WFN) initiative has transformed into a collaborative movement between the World Health Organization, the International League Against Epilepsy and the International Bureau of Epilepsy. This year, July 22 marked a special day in the history of neurology advocacy.

National societies prepared activities, including press conferences, media briefings, CME seminars, public awareness gatherings, awareness walks, epilepsy camps and various other activities for individuals with epilepsy and their families. National neurology societies collaborated with national epilepsy societies and patient support groups for World Brain Day activities.

The WFN Public Awareness and Advocacy Committee prepared a World Brain Day poster, brochure and PowerPoint presentation for media briefing. Banners for display on websites and Facebook pages also were available for promotion of this global activity. Press releases were issued in many languages to all major global newspapers and news agencies.

The main objective of World Brain Day is to promote brain health by preventing and caring for neurological diseases. This year’s theme was epilepsy. All of our awareness campaigns were dedicated toward epilepsy care.

The goal was to reach about 100 million people around globe through these multilingual, multimedia campaign jointly organized by WFN, the World Health Organization, International League Against Epilepsy and International Bureau for Epilepsy.

Mohammad Wasay, MD, FRCP, FAAN, is chair of the Public Awareness and Advocacy Committee.

Applied Research Group in Neurological Infections Launches

By Kiran Thakur, MD, and Sarosh Katrak, MD, DM, FRCP(E)

Neurological infections continue to ravage populations in developing and developed countries. In many regions, central nervous system (CNS) opportunistic infections due to AIDS and tropical diseases remain a major contributor to morbidity and mortality.

In resource-rich settings, where new immunomodulatory medications are being frequently used, CNS infections are being increasingly recognized. There are a growing number of emerging and re-emerging neurotropic infectious diseases, and proper diagnosis and management often require neurologic expertise that may not be available in certain global regions.

Despite significant scientific advances in the field, the burden of undiagnosed neurological infections remains unacceptably high. Major research gaps exist in our understanding of the pathogenesis and cost-effective diagnostics, as well as the CNS penetration and optimal treatment schedules of many neurological infections.

As co-chairs of the newly established applied research group in neurological infections, we are excited to enhance the education, training and research in neurological infections to the global neurology community. The World Federation of Neurology is well positioned to make a major impact in this field through its representation of more than 100 countries, many of which have neurologists with expertise in neurological infections.

We hope to engage experts in neurological infections in collaborative research and educational projects and those interested in improving their knowledge of neurological infectious diseases. We encourage those interested in participating to become members and participate in the educational and research endeavors of our group.

Research Goals

  • Surveillance of emerging and re-emerging neurological infections
  • Continued vigilance in understanding the burden of CNS opportunistic infection risk in patients on immunomodulatory therapies
  • Surveillance of undiagnosed infectious diseases in the global community
  • Enhanced pathogen discovery testing globally, with increased access to advanced testing in resource-limited settings
  • Drug-development trials, including studies on CNS penetration of medications for neurological infections and setting drug-dosing and treatment protocols specific for CNS infections

Training and Educational Goals

  • Develop and enhance educational sessions on neurological infections at the World Congress of Neurology meetings
  • Training sessions in neuroinfectious diseases for general practitioners and neurologists
  • Develop training modules on neurological infections with a focus on acute meningitis/encephalitis, chronic meningitis, opportunistic infections in immunosuppressed patients, viral encephalitis and tropical neurology
Kiran Thakur, MD, is an assistant professor in the department of neurology at Columbia University College of Physicians and Surgeons, New York, and Sarosh Katrak, MD, DM, FRCP(E), is director of the department of neurology at Jaslok Hospital and Research Centre, in Mumbai, India.

AFNA, AKUH Team Up for Training, Telemedicine

By Esmatullah Hamed, MD

Esmatullah Hamed

Esmatullah Hamed

Trained neurologists are lacking in Afghanistan. Neurological disorders are one of the major disease burdens in this part of the world, and training in this area is scarce. EEG interpretation both in children and adults is a specialized job, and grave errors can occur in patient management when misinterpretations occur.

The Afghan Neurological Association (AFNA) was established to promote the development of clinical neurology and neurological science throughout the country and to promote friendship among neurologists in Afghanistan and the region.

The AFNA formed collaborations with Aga Khan University Hospital (AKUH) Karachi for assessment and identification of strategic training requirements based on the country’s key health care needs. The program is evolving with training arms supporting residents and physicians.

The program not only focuses on the training aspect of physicians, but it also reaches patients in the far parts of Afghanistan with the (FMIC) Medical Institute for Children conducting telemedicine neurology clinics. This effort gives patients access to a modern health facility and expert neurologists in Kabul. To get expert opinions, telemedicine clinics also are conducted with AKUH Karachi.

Regular conferences and workshops are major components of the AFNA, AKU collaboration.

Regular conferences and workshops are major components of the AFNA, AKU collaboration.

One of the major components of training and sharing knowledge is through regular conferences and workshops. A major function of such meetings of neurology is to facilitate the sharing of knowledge and to help develop ongoing working relationships that can lead to many advances for all. Although publications and electronic communications provide essential ways to communicate, an international meeting offers unparalleled access to peers whose workplaces and problems are far from home, but may be extremely informative.

Both information sharing and clinical and research collaboration become real possibilities. Clinical collaboration today often takes the form of setting up periodic videoconferences, supplementing important opportunities to visit each another.

In this regard, the second Neurology Certificate Course was conducted via video conference June 6-9 in Kabul in collaboration with the FMIC, the Afghan Neurological Association and Aga Khan University in Karachi.

AFNA, AKUH meetings of neurology facilitate knowledge sharing and help develop ongoing working relationships.

AFNA, AKUH meetings of neurology facilitate knowledge sharing and help develop ongoing working relationships.

Seventeen speakers from neurology, neurosurgery, psychiatry and radiology departments participated, among which 14 were from the Aga Khan University and three speakers from Kabul. The World Federation of Neurology and the Asian Ocean Association of Neurology provided funding for this course.

The lectures covered a broad spectrum of neurological disorders, including stroke, central nervous system infections, headaches, epilepsy, neurological Investigations, coma and brain death.

Seventy residents and physicians participated in the conference from different parts of Afghanistan. The levels of interest were clear by the high level of engagement during the each question-and-answer period at the end of each session, participant feedback after the course revealed that the participants highly appreciated the course and called on planners for more frequent courses.

Esmatullah Hamed, MD, is president of the Afghan Neurological Association and consultant neurologist at the French Medical Institute for Children, Kabul, Afghanistan.

The Hansen-Neisser Controversy Concerning the Discovery of Mycobacterium Leprae

By Douglas J. Lanska

Douglas J. Lanska

Douglas J. Lanska

In the late 1860s, on the basis of his clinical and anatomical studies, Norwegian physician Gerhard Armauer Hansen (1841-1912) concluded preliminarily that leprosy was a distinct disease with a specific cause, and not simply a degenerative condition with multiple potential etiologies. (See Figures 1 and 2.) His subsequent epidemiological studies in Norway found no association between the occurrence of leprosy in various districts and general mortality rates, provided evidence that leprosy was contagious rather than hereditary, and demonstrated that isolation of cases produced a decline in incidence.

In 1873, Hansen discovered rod-shaped bodies — Mycobacterium Leprae, sometimes called Hansen’s bacillus — in leprous nodules, although he did not clearly identify them as bacteria. He described these in a report to the Medical Society of Christiania (now Oslo) and in his main treatise in 1874, with a shorter English version in 1875:

Figure 1. Gerhard Armaner Hansen. Photograph by J.F. Lehman, Munich, 1912. Public domain. Courtesy of the U.S. National Library of Medicine.

Figure 1. Gerhard Armaner Hansen. Photograph by J.F. Lehman, Munich, 1912. Public domain. Courtesy of the U.S. National Library of Medicine.

“While leprosy may be … indirectly proved to be a specific disease by demonstrating its contagiousness, it would, of course, be the best if a direct proof could be given. I will briefly mention what seems to indicate, that such proof is, perhaps, attainable. There are to be found in every leprous tubercle extirpated from a living individual — and I have examined a great number of them — small staff-like bodies, much resembling bacteria, lying within the cells; not in all, but in many of them. Though unable to discover any difference between these bodies and true bacteria, I will not venture to declare them to be actually identical. Further, while it seems evident that these low forms of organic life [i.e., bacteria] engender some of the most acute infectious diseases, the attributing of the origin of such a chronic disease as leprosy to the apparently same matter must, of course, be attended with still greater doubts. It is worthy of notice, however, that the large brown elements found in all leprous proliferations in advanced stages … bear a striking likeness to bacteria in certain stages of development … .”

Figure 2. A 24-year-old Norwegian man with lepromatous leprosy. From Leloir H. Traité pratique et théorique de la lè
pre. Paris: A. Delahaye et Lecrosnier. 1886. This figure was later reprinted by Hansen in his monograph (1895). Public domain. Courtesy of the Bibliothè
que nationale de France.

Figure 2. A 24-year-old Norwegian man with lepromatous leprosy. From Leloir H. Traité pratique et théorique de la lè
pre. Paris: A. Delahaye et Lecrosnier. 1886. This figure was later reprinted by Hansen in his monograph (1895). Public domain. Courtesy of the Bibliothè
que nationale de France.

Hansen tried unsuccessfully to stain his preparations. In 1879, when Hansen was visited by Albert Neisser (1855-1916), a young colleague from the laboratory of German physician and pioneering microbiologist Robert Koch (1843-1910) in Breslau, Hansen, encouraged him to try to stain the bacteria. (See Figure 3.) Shortly after Neisser returned to Breslau, he succeeded in staining the bacteria, and then promptly announced his findings, suggested that these bacteria were indeed the infectious agent of leprosy, and claimed priority for the discovery.

Hansen replied quickly and tried to assert his own priority, and by 1880 he had also succeeded in staining the bacteria. (See Figure 4.)

Figure 3. Albert Neisser. Public domain. Courtesy of the U.S. National Library of Medicine.

Figure 3. Albert Neisser. Public domain. Courtesy of the U.S. National Library of Medicine.

“It was not my intention to make any of my investigations on this subject public at present, but as not only Dr. Edlund to whom in the preceding year I showed preparations, and mentioned that I considered leprosy a parasitic disease, in his little work on ‘Leprosy’ speaks of its precise origin as something that he has discovered in the form of “micrococci,” by also Dr. Neisser, of Breslau, who passed some portion of this summer in Bergen has just published the result of his investigations of those preparations that he made while here, and as these results also point out that in general, the preparations are filled with ‘bacilli’ which he supposes to be peculiar to leprosy, and as its ‘contagium’— I feel myself called upon to announce what I have attained to, up to the present time, in my researches after the same ‘contagium,’ and, this, partly to assert my priority with reference to this discovery, and partly in order to advance those details in research which I omitted to announce on account of the still uncertain result in my report to the Medical Society of Christiania [Oslo], 1874, concerning my investigations into the etiology of leprosy.”

Figure 4. Left: Hansen's drawing (1880) of “brown elements colored with methyl violet, from a tubercle treated with osmic acid.” From Hansen (1880). Right: A photomicrograph of Mycobacterium Leprae (small red rods), taken from a leprosy skin lesion. Public domain. Courtesy of the U.S. Centers for Disease Control and Prevention, Public Health Image Library (PHIL) #2123.

Figure 4. Left: Hansen’s drawing (1880) of “brown elements colored with methyl violet, from a tubercle treated with osmic acid.” From Hansen (1880). Right: A photomicrograph of Mycobacterium Leprae (small red rods), taken from a leprosy skin lesion. Public domain. Courtesy of the U.S. Centers for Disease Control and Prevention, Public Health Image Library (PHIL) #2123.

Although an international consensus generally favored Hansen in this priority dispute as the discoverer of Mycobacterium Leprae, neither Hansen nor Neisser succeeded in fulfilling Henle’s postulates — the criteria to establish a causative relationship between a microbe and a disease propounded in 1840 by German physician, pathologist and anatomist Jakob Henle (1809-1885):

  1. The microbe occurs in every case of the disease under circumstances that account for the pathological changes and clinical course of the disease;
  2. The microbe occurs in no other disease as a nonpathogenic parasite; and
  3. After being isolated and grown in pure culture in an artificial medium, it can induce the disease in an experimental host. These criteria were later augmented by Koch and subsequently known as the Henle-Koch postulates.

Neither Hansen nor Neisser demonstrated that the bacteria observed in cases of leprosy were specific to that disease, nor was Hansen able to transmit the disease to animals or humans using leprous material from patients. Hence, at the time of the Hansen-Neisser controversy, it remained unproven that leprosy is infectious, despite even an unethical attempt by Hansen to transmit leprosy to a patient without informed consent. Furthermore, to this day Mycobacterium Leprae has not been grown in pure culture in an artificial medium.

References:

  1. Evans AS. Causation and Disease: The Henle-Koch Postulates Revisited. Yale J.
  2. Biol Med. 1976;49(2):175-195.
  3. Fite GL, Wade HW. The Contribution of Neisser to the Establishment of the Hansen Bacillus as the Etiologic Agent of Leprosy and the So-called Hansen-Neisser Controversy. Int J Lepr. 1955;23:418-428.
  4. Hansen GA. Spedalskhedens Arsager (causes of leprosy). Translation by Pierre Pallamary. Intl J Leprosy 1955;23:307-309.
  5. Hansen GA. On the Etiology of Leprosy. Br Foreign Medico-chirurgical Rev 1875;55:459-489.
  6. Hansen A. The Bacillus of Leprosy. Q J Microscopical Sci 1880;20:92-102.
  7. Hansen GA, Looft C. Leprosy: In Its Clinical & Pathological Aspects. Translated by Norman Walker. Bristol: John Wright & Co., 1895.
  8. Irgens LM. The Discovery of Mycobacteriom Leprae: A Medical Achievement in the Light of Evolving Scientific Meathods. Am J Dermatopathol 1984;6(4):337-343.
  9. Vogelsang TM. The Hansen-Neisser Controversy, 1879-1880. Int J Lepr. 1963;31:74-80.
  10. Vogelsang TM. Gerhard Henrik Armauer Hansen: 1841-1912: The Discoverer of the Leprosy Bacillus. His Life and his Work. Int J Lepr 1978;46:257-332.
  11. Peter J Koehler is the editor of this history column. He is neurologist at Atrium Medical Centre, Heerlen, The Netherlands. Visit his website at www.neurohistory.nl.

 

 

World Federation of Neurology Teaching Centers

The World Federation of Neurology (WFN) has established Teaching Centers for training young neurologists in Africa. The first Teaching Center opened at the Department of Neurology of Mohamed V. Souissi University in Rabat in 2014, and now also the Department of Neurology of Cairo University will participate.

The WFN will offer a three-year training course in Rabat (French speaking), and a one-year training course in Cairo (English speaking), starting in September 2015. The WFN will cover travel costs, tuition and a monthly allowance for living expenses for this period.

Persons from Africa can apply for a teaching course in either Rabat or Cairo, according to the conditions and criteria specified on the WFN website.

To apply, applicants must submit their CV, a supporting statement indicating which training program they wish to apply for and a letter of recommendation from the dean of their department by Friday, July 3, 2015, by email to enkanagu@kenes.com. The applications will be accepted from Friday, May 15, 2015, until Friday, July 3, 2015. A commission of the WFN will select the most suitable candidates. For more information on the training programs, the selection criteria and the process, visit the WFN website: www.wfneurology.org.

 

 

International Coursework

INTERNATIONAL DIPLOMA IN MENTAL HEALTH, HUMAN RIGHTS AND LAW

The International Diploma on Mental Health, Human Rights and Law is currently accepting applications for the academic year 2015-16. The diploma, now in its eighth year, is a collaboration between the World Health Organization and the ILS Law College in Pune, India. The course builds the capacity of students to advocate for human rights and to influence national legislative and policy and service reform in line with the U.N. Convention on the Rights of Persons with Disabilities and other key international human rights standards. It is a one-year diploma and includes two residential sessions and distance learning.

Students to date comprise health and mental health professionals, lawyers, mental health service users/survivors, government officials, social workers, human rights defenders, families and careers. The course is taught be a faculty of renowned international experts in the area.

More information about the diploma is also available at www.cmhlp.org/diploma.

The prospectus and application forms are available at http://cmhlp.org/applications-and-fees/download-prospectus-and-forms.

In addition, the Open Society Institute (OSI) will provide funding for two students from Central and Eastern Europe/former Soviet Union to participate in the course. These are fully funded fellowships and include tuition fees, travel, accommodations and living expenses for the residential sessions. If you are interested and qualify for this grant, please state on your application that you wish to be considered for the OSI fellowships.

INTERNATIONAL MASTER IN MENTAL HEALTH POLICY AND SERVICES

The International Master in Mental Health Policy and Services, an international course promoted by the NOVA University of Lisbon in collaboration with WHO, is currently accepting applications for the academic year 2015-2017. The main scope of the Master Degree in International Mental Health Policy and Services (MHPS) is to build capacity of mental health professionals to lead and contribute to conceiving, formulating, implementing and evaluating:

  • national mental health policy
  • national mental health legislation
  • mental health services and care delivery

The course will start Monday, Oct. 12, 2015, with a two-week residential session, at the Faculdade de Ciàªncias Médicas campus in Lisbon. A second two-week residential session will take place April 4 in Lisbon. Between the two residential sessions, the students will participate in e-learning teaching activities under the orientation of supervisors.

The second year of the course will be dedicated to the development of a project and the elaboration of the dissertation, under the orientation of a supervisor. Additional information about the course can be found at the following site: www.fcm.unl.pt.

Epilepsy: Theme for World Brain Day 2015

By Mohammad Wasay and Wolfgang Grisold

WBD-logo

Scenic Santiago, Chile, is the host city for the Congress

Epilepsy is one of the most common neurological diseases in world with an estimated more than 50 million people affected around world. It affects people of all ages. Almost 50 percent have a cause for these epileptic seizures, including stroke, brain trauma, infections, tumors or brain damage during or before delivery of a baby. It may cause three to six times increase risk of premature death. More than 80 percent live in developing countries, and almost 70 percent do not receive any treatment. Stigma and discrimination are important aspects of this treatable disease. More than 70 percent of people with epilepsy can lead a normal life with treatment. These were the facts and figures that inspired the World Federation of Neurology to select “epilepsy” as a theme for 2015 World Brain Day campaign.

2015 is a landmark year in history of epilepsy. The World Health Assembly adopted the resolution, titled “Global burden of epilepsy and the need for coordinated actions at the country level to address its health, social and public knowledge implications.” This resolution is a call for action from member countries and stakeholders.

The World Brain Day campaign will be jointly organized by WFN, the International League Against Epilepsy (ILAE) and the International Bureau of Epilepsy (IBE). Both of these organizations have been working for decades to improve public awareness, doctors’ training and advocacy. We urge our delegate societies to work with local ILAE and IBE chapters to organize World Brain Day 2015 activities. Our campaign will focus on prevention of epilepsy.

The Public Awareness and Advocacy Committee is in the process of preparing publicity material for this campaign. The material will include logos, banner ads for websites, handbills, brochures, posters, billboards and presentations. There will be a press conference in collaboration with the World Health Organization. A multilanguage press release will be prepared and circulated to delegate societies.

The most important target of this campaign is the public. We need to create simple messages in local languages and promote them via electronic, social media, billboards, banner and events. The next important area of intervention is health care authorities and policymakers. Our campaign should result in policy and priority shifts at the national or local level. We have to plan targeted activities to facilitate this outcome. Another important area of intervention is awareness and training of general practitioners, nurses and paramedical staff. Involvement of media is a must. Celebrities, scientists and sports figures with epilepsy could be a part of this advocacy campaign.

World Brain Day 2014 was a great success due to participation of large number of delegate national societies organizing activities and media events. Hundreds of newspaper items and media posts were created and shared via electronic, print and social media.

World Brain Day 2015 will be extremely productive in spreading the message all around globe, not only to affected people, doctors and health care authorities but to those normal, healthy people who are at risk for developing epilepsy. We can defeat epilepsy by awareness and effective treatment.

Wasay is the chair of the Public Awareness and Advocacy Committee.

Editor’s Update and Selected Articles from the Journal of Neurological Sciences (JNS)

By John D. England

John D. England, MD

John D. England, MD

On April 21, 2015, the Editorial Board of the Journal of the Neurological Sciences (JNS) met in Washington, DC. I’m pleased to report that by all measures JNS has shown steady and healthy growth. The number of manuscripts that are submitted to the journal has continued to increase over the past several years. Specifically, 1,718 manuscripts were submitted and reviewed in 2014, compared to 1,520 in 2013. Additionally, the number of full text article downloads via Science Direct increased from 764,832 in 2013 to 807,404 in 2014.

By all current indicators, these numbers are expected to increase for 2015. Because JNS is the official journal of the World Federation of Neurology (WFN), the Editorial Board welcomes submissions from around the world. As a measure of this aim, JNS receives articles from authors and institutions around the globe. The majority of submissions come from Asia, Western Europe and North America (U.S. and Canada).

As a reflection of the continuing globalization of science and technology, the journal has seen a significant increase in the number of papers from Eastern Europe, the Middle East and Africa. Although a new impact factor (IF) for the journal will not be calculated until later in 2015, we are hopeful that these positive trends will also result in an increase in the IF over the next few years.

In our ongoing attempt to enhance accessibility of JNS articles to WFN members, we have selected two more “free-access” articles, which are profiled in this issue of World Neurology. These articles are paired and are presented together.

1) Apostolos Safouris, et al, provide an interesting and instructive case description of an older man with probable Alzheimer’s disease who presented with an episode of acute motor aphasia, which was initially diagnosed as a transient ischemic attack (TIA). Although an initial brain CT-scan did not demonstrate an acute lesion, a gradient-echo MRI performed within the first 48 hours revealed a left cortical parietal microbleed (MB). The authors argue persuasively that the MB was probably responsible for the patient’s symptoms and was likely associated with cerebral amyloid angiopathy (CAA). The authors suggest that patients with known or probable CAA (especially those with Alzheimer’s disease) not undergo thrombolysis or anticoagulation for a possible ischemic stroke until amyloid-associated MB is excluded. Safouris A, Gazagnes M-D, Triantafyllou N, Tsivgoulis G. Cerebral amyloid angiopathy-associated microbleed mimicking transient ischemic attack. J Neurol Sci 2015;351:198-199.

2) In an accompanying editorial, Andreas Charidimou provides a succinct and useful perspective on cerebral amyloid disease. He points out that sporadic cerebral amyloid angiopathy (CAA) is a common neuropathological finding in the aging brain, and it is especially notable in the brains of individuals with Alzheimer’s disease. CAA is an important risk factor for spontaneous lobar intracerebral hemorrhage and anticoagulant — associated brain hemorrhage. Dr. Charidimou points out that transient focal neurological spells, sometimes called “amyloid spells,” are well described and probably more common than is generally appreciated. Since these transient episodes can be misdiagnosed as TIAs, he emphasizes the importance of obtaining a brain MRI to exclude a microbleed in the investigation of older individuals with otherwise unexplained transient neurological episodes. Charidimou A. Elderly and forgetful with transient neurological spells: A story of two amyloids? J Neurol Sci 2015;351:1-2.

Dr. England is the editor-in-chief of the Journal of the Neurological Sciences.

 

 

 

Neurosonology in Egypt

By Prof. Foad Abd-Allah

headshot_Foad

Foad Abd-Allah

The Cairo University Neurosonology Unit (CUNU) is a distinguishable, highly specialized center for sonographic assessment of the nervous system. The unit was founded in 2006, and, since then, it has become a hub for large volume sonology service provision, education and research activities. Team members in the unit are highly trained and practice the state-of-the-art of neurosonology.

The unit was established following the post-doctoral scientific visiting fellowships of Dr. Foad Abd-Allah, founder of the unit, first with Prof. David Russell at Rikshospitalet, the National Teaching Hospital in Oslo, Norway, and then with Prof. Manfrad Kaps at Gissen University, Germany, during the 2004-2005 academic year. Thereafter, the department procured a color duplex ultrasound machine. Coupled with the interest of senior doctors in the department and the enthusiasm of young neurologists, training in neurosonology was started. Currently, the unit possesses four pieces of equipment, with well-trained operators working within two lab facilities. Most of the members of CUNU are certified by the Intersociety Commission for Certification in Neurosonology, the Neurosonology Research Group of the World Federation of Neurology (NSRG) and European Society of Neurosonology and Cerebral Hemodynamic.

CUNU provides high-quality, high- impact services in a timely fashion for patients with neurological disorders. More than 1,200 cases are examined every year by its team. The mainstay of the service is the neurovascular assessment of stroke patients to tackle steno-occlusive disease of cerebral vasculature. Additionally, follow up of patients with subarachnoid hemorrhage for vasospasm as well as cerebral circulatory arrest in brain death is another important task. Recently, nerve muscle neurosonology was introduced. The diagnostic possibilities of neuro-ultrasound have not yet been exhausted. Anyone interested in neurosonology is offered a comprehensive initiation into this fascinating diagnostic tool.

Foad-TeamThe neurosonology team members created a training program, titled “The Neurosonology Professional Diploma.” The course is designed in five comprehensive modules to be presented annually from October to June, and provides candidates with basic theory and practical skills in commonly applied neurosonology techniques. The NSRG of the World Federation of Neurology reviewed the program and certified it as an outstanding high standard teaching program. Many candidates already expressed their interest in it. Full details of the program can be found at www.medicine.cu.edu.eg/cunu/index.html.

The Neurosonology Annual Workshop was launched in 2008, in collaboration with Prof. Manfred Kaps from Giessen, Germany, and since then it has become a landmark event in the annual neurology conference in Egypt. Every year, a new topic is presented in this conference with more than 100 attendees; some of whom have received training in the CUNU lab and eventually have gone on to establish their own laboratories in their respective departments.

CUNU supports candidates for their master’s and PhD theses. Since 2006, team members have performed more than 20 projects for both master’s and doctoral degrees. In addition, many post-doctoral research projects have been completed and even published in peer reviewed journals. The main research interest of our group is the role of ultrasound in cerebrovascular and neurocritical care.

Last month, the WFN Educational Board visited the department of Neurology at Cairo University for accreditation as a training center for English-speaking countries in Africa. The visiting board was impressed by the department as a whole, and many positive comments were received with special attention to the neurosonology unit, recognizing it as “exceptional.”

Abd-Allah is professor of neurology and stroke medicine and head of the neurosonology unit at Cairo-University, Egypt. He is also an executive member of the Neurosonology Research Group of WFN and the WSO board of directors for Middle East and North Africa.

WFN Election 2015: Nominating Committee Recommendations

The Nominating Committee of the World Federation of Neurology, having invited nominations for one treasurer and one elected trustee post, both to be filled with effect from the 2015 Annual General Meeting (Council of Delegates) on Nov. 1, recommends the following candidates to the membership:

Recommended candidates:

Treasurer:

  • Prof. Richard Stark (Australia)
  • Prof. Andreas Steck (Switzerland)

Elected Trustee:

  • Prof. Morris Freedman (Canada)
  • Prof. Steven Lewis (USA)

It is open to anyone to make additional nominations by

  • Obtaining the supporting signatures of five or more authorized delegates
  • Submitting the name(s) of the individual(s) in question to the Secretary-Treasurer General, c/o the London Secretariat office, to arrive at least 30 days prior to the date of the Council of Delegates meeting.